Nanjing Vazyme Biotech Co Ltd
SSE:688105
Wall Street
Price Targets
Price Targets Summary
Nanjing Vazyme Biotech Co Ltd
According to Wall Street analysts, the average 1-year price target for Nanjing Vazyme Biotech Co Ltd is 43.72 CNY with a low forecast of 36.08 CNY and a high forecast of 52.5 CNY.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Nanjing Vazyme Biotech Co Ltd
For the last 3 years the compound annual growth rate for Nanjing Vazyme Biotech Co Ltd's operating income is 227%. The projected CAGR for the next 3 years is -24%.
Net Income
Forecast
Net Income Estimate
Nanjing Vazyme Biotech Co Ltd
For the last 3 years the compound annual growth rate for Nanjing Vazyme Biotech Co Ltd's net income is 185%. The projected CAGR for the next 3 years is -12%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Nanjing Vazyme Biotech Co Ltd's stock price target?
Price Target
43.72
CNY
According to Wall Street analysts, the average 1-year price target for Nanjing Vazyme Biotech Co Ltd is 43.72 CNY with a low forecast of 36.08 CNY and a high forecast of 52.5 CNY.
What is Nanjing Vazyme Biotech Co Ltd's Revenue forecast?
Projected CAGR
-17%
For the last 3 years the compound annual growth rate for Nanjing Vazyme Biotech Co Ltd's revenue is 137%. The projected CAGR for the next 3 years is -17%.
What is Nanjing Vazyme Biotech Co Ltd's Operating Income forecast?
Projected CAGR
-24%
For the last 3 years the compound annual growth rate for Nanjing Vazyme Biotech Co Ltd's operating income is 227%. The projected CAGR for the next 3 years is -24%.
What is Nanjing Vazyme Biotech Co Ltd's Net Income forecast?
Projected CAGR
-12%
For the last 3 years the compound annual growth rate for Nanjing Vazyme Biotech Co Ltd's net income is 185%. The projected CAGR for the next 3 years is -12%.